COMPANION KC BIVALENT INACTIVATED VACCINE FOR DOGS

국가: 오스트레일리아

언어: 영어

출처: APVMA (Australian Pesticides and Veterinary Medicines Authority)

유효 성분:

ALUMINIUM HYDROXIDE; BORDETELLA BRONCHISEPTICA (INACTIVATED CELL FREE EXTRACT; CANINE PARAINFLUENZA VIRUS - INACTIVATED

제공처:

INTERVET AUSTRALIA PTY LIMITED

INN (국제 이름):

vaccine - canine Bordetella(0.05ug/dose) + others

약제 형태:

MISC. VACCINES OR ANTI SERA

구성:

ALUMINIUM HYDROXIDE MINERAL-ALUMINIUM-BASE Active 3.0 mg/do; BORDETELLA BRONCHISEPTICA (INACTIVATED CELL FREE EXTRACT VACCINE-MICROBIAL Active 0.05 ug/do; CANINE PARAINFLUENZA VIRUS - INACTIVATED VACCINE-VIRAL Active 0.0 Undefined

패키지 단위:

1 SD Vial; 10 SD Vls; 20 SD Vls; 25 SD Vls; 40 SD Vls; 5 SD Vials; 50 SD Vls; Vial = 1mL

수업:

VM - Veterinary Medicine

Manufactured by:

INTERVET AUSTRALIA

치료 그룹:

DOG - WITH EXCLUSIONS SEE LABEL

치료 영역:

IMMUNOTHERAPY

치료 징후:

BORDETELLA BRONCHISEPTICA | CANINE PARAINFLUENZA | CANINE COUGH SYNDROME | INFECTIOUS TRACHEOBRONCHITIS

제품 요약:

Poison schedule: 0; Withholding period: WHP: N/A.; Host/pest details: DOG - WITH EXCLUSIONS SEE LABEL: [BORDETELLA BRONCHISEPTICA, CANINE PARAINFLUENZA]; Poison schedule: 0; Withholding period: ; Host/pest details: DOG - WITH EXCLUSIONS SEE LABEL: [BORDETELLA BRONCHISEPTICA, CANINE PARAINFLUENZA]; For the active immunisation of dogs against Bordetella bronchiseptica and canine parainfluenza virus.AVOID USING in dogs receiving corticosteroids and in pregnant bitches.

승인 상태:

Registered

승인 날짜:

2023-07-01

환자 정보 전단

INTERVET AUSTRALIA PTY LIMITED
COMPANION KC BIVALENT INACTIVATED VACCINE FOR DOGS
COMPANY NAME:
PRODUCT NAME:
PRODUCT NO:
LABEL NAME:
COMPANION KC BIVALENT INACTIVATED VACCINE FOR DOGS
SIGNAL HEADINGS:
FOR ANIMAL TREATMENT ONLY
CONSTITUENT
STATEMENTS:
ACTIVE CONSTITUENTS:
Each single dose vial contains (minimum titres):
-purified inactivated Bordetella bronchiseptica antigen….0.05 µg
-inactivated canine parainfluenza virus………… 10^6TCID50
-aluminium hydroxide (adjuvant)……………3 mg
CLAIMS:
For the active immunisation of dogs against Bordetella bronchiseptica
and canine
parainfluenza virus.
NET CONTENTS:
1 dose vial (1 mL)
5 single dose vials
10 single dose vials
20 single dose vials
25 single dose vials
40 single dose vials
50 single dose vials
DIRECTIONS FOR USE:
DIRECTIONS FOR USE:
Only healthy dogs possessing normal temperatures should be vaccinated.
CONTRAINDICATIONS:
CONTRAINDICATIONS:
This product should not be used in dogs receiving corticosteroids or
in pregnant bitches.
SIDE EFFECTS:
SIDE EFFECTS
Local reactions may occur at inoculation sites in some dogs.
DOSAGE AND
ADMINISTRATION:
DOSAGE AND ADMINISTRATION:
Note: The removable label should only be removed after the dose has
been given.
Under normal circumstances:
Primary vaccination:
56441/100839 RLP APPROVED
For Official Use Only
Inject subcutaneously or intramuscularly 2 doses of vaccine at an
interval of 1 month to
dogs 6 weeks of age or over. Companion® KC Vaccine is suitable for
use as a diluent with
Companion® C3.
Under severe infectious risk, susceptible puppies may benefit from an
early start to the
vaccination program (6 weeks of age). Vaccination at 2 to 3 week
intervals through until 16
weeks of age may also be appropriate in high risk situations.
An annual booster is recommended.
GENERAL DIRECTIONS:
Due to the interference of maternal antibodies with active
immunisation, protection of young
puppies can be difficult, especially in infected kennels.
Epidemiological conditions and the
likely persistence of maternal antibodie

제품 특성 요약

PRODUCT NAME: COMPANION™ KC BIVALENT INACTIVATED VACCINE
FOR DOGS
MATERIAL SAFETY DATA SHEET
THIS REVISION ISSUED: JULY, 2009
PAGE: 1 OF 5
MATERIAL SAFETY DATA SHEET
Issued by: Intervet Australia Pty Limited Phone: [phone]
(Business Hours)
Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800
764 766 in New Zealand)
SUBSTANCE:
Companion KC Bivalent Inactivated Vaccine for Dogs.
TRADE NAME:
COMPANION™ KC BIVALENT INACTIVATED VACCINE FOR DOGS
PRODUCT CODE:
3975
RECOMMENDED USE:
For the active immunisation of dogs against _Bordetella
bronchiseptica_ and Canine
parainfluenza virus.
APVMA NO:
56441
CREATION DATE:
November, 2006
THIS VERSION ISSUED:
July, 2009
and is valid for 5 years from this date.
STATEMENT OF HAZARDOUS NATURE:
THIS PRODUCT IS CLASSIFIED AS:
Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG)
Code.
RISK PHRASES:
Not Hazardous - No criteria found.
SAFETY PHRASES:
None allocated.
SUSDP CLASSIFICATION:
None allocated.
ADG CLASSIFICATION:
None allocated. Not a Dangerous Good under the ADG Code.
UN NUMBER:
None allocated
PHYSICAL DESCRIPTION & COLOUR:
Slightly opaque pink liquid.
ODOUR:
No odour.
MAJOR HEALTH HAZARDS:
no significant risk factors have been found for this product.
INHALATION:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. However
product may be mildly
irritating, although unlikely to cause anything more than mild
transient discomfort.
LONG TERM EXPOSURE:
No data for health effects associated with long term inhalation.
SKIN CONTACT:
SHORT TERM EXPOSURE:
Available data indicates that this product is not harmful. It should
present no hazards in
normal use. In addition product is unlikely to cause any discomfort in
normal use.
LONG TERM EXPOSURE:
No data for health effects associated with long term skin exposure.
EYE CONTACT:
SHORT TERM EXPOSURE
: This product may be mildly irritating to eyes, but is unlikely to
cause anything more than mild
discomfort wh